Skip to main content
Caplight Logo









Zilia

Zilia

Private
CanadaHealthcare & Life Scienceshttps://ziliahealth.com/

Last Round

Debt

May 7, 2025

Total Funding Raised

$4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Zilia is a health technology company that develops a non-invasive medical platform to measure biomarkers in the eye for the early diagnosis and management of ocular, neurological, and systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

medical deviceophthalmologyretinal imagingspectrophotometryeye healthmedical AIbiomarker measurementnon-invasive diagnosticsdigital healthmedtechoxygen saturationclinical diagnosticshealthcare analyticsAI diagnosticseye care software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zilia Comparables

Compare Zilia with similar companies based on industry and business-model similarity.

Zilia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vasoptic Medical, Inc.
79%
Imagine Eyes
75%
AMETEK, Inc.
66%

Zilia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 7, 2025
SeedAug 11, 2021

Key People

Founding team and executive leadership

Dominic Sauvageau

Co Founder and CTO

Founding Team

Patrick Sauvageau

CEO and co-founder

Founding Team

Robin Villeneuve

CFO

Executive Team

Zilia Investors

Notable investors and investment history

Zilia investors
InvestorRounds
Investissement QuébecSeed
Anges QuebecSeed
Linearis VenturesDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 196% MoM, reaching 865.

  • Mar 3, 2026

    Monthly visitors increased 190% MoM, reaching 7.4K.

Zilia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zilia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zilia's valuation, stock price, and market status.

Firmographic Details

HeadquartersCanada
Employee Range31
Year Founded2017
Last FundingMay 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?